Drug Resistance, Microbial
"Drug Resistance, Microbial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Concept/Terms
Drug Resistance, Microbial- Drug Resistance, Microbial
- Drug Resistances, Microbial
- Antimicrobial Drug Resistance
- Antimicrobial Drug Resistances
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Microbial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Microbial".
This graph shows the total number of publications written about "Drug Resistance, Microbial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Microbial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 29 | 30 |
| 1993 | 3 | 25 | 28 |
| 1994 | 4 | 12 | 16 |
| 1995 | 4 | 15 | 19 |
| 1996 | 7 | 36 | 43 |
| 1997 | 14 | 21 | 35 |
| 1998 | 6 | 37 | 43 |
| 1999 | 7 | 35 | 42 |
| 2000 | 8 | 34 | 42 |
| 2001 | 8 | 26 | 34 |
| 2002 | 4 | 8 | 12 |
| 2003 | 2 | 5 | 7 |
| 2004 | 0 | 4 | 4 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 6 | 8 |
| 2008 | 6 | 1 | 7 |
| 2009 | 2 | 5 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 6 | 5 | 11 |
| 2013 | 9 | 5 | 14 |
| 2014 | 12 | 10 | 22 |
| 2015 | 8 | 3 | 11 |
| 2016 | 3 | 5 | 8 |
| 2017 | 3 | 7 | 10 |
| 2018 | 8 | 5 | 13 |
| 2019 | 8 | 6 | 14 |
| 2020 | 6 | 8 | 14 |
| 2021 | 3 | 5 | 8 |
Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond? Adv Drug Deliv Rev. 2022 01; 180:114057.
-
Prevalence, Costs, and Consequences of Low-Value Preprocedural Urinalyses in the US. JAMA Intern Med. 2021 11 01; 181(11):1533-1535.
-
Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS). Lancet Infect Dis. 2021 12; 21(12):1677-1688.
-
Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium falciparum Malaria in Bohicon and Kandi, Republic of Benin, 2018-2019. Am J Trop Med Hyg. 2021 07 12; 105(3):670-676.
-
High-throughput functional variant screens via in vivo production of single-stranded DNA. Proc Natl Acad Sci U S A. 2021 05 04; 118(18).
-
Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients. Burns. 2021 12; 47(8):1833-1843.
-
Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity. Eur J Med Chem. 2021 Apr 05; 215:113227.
-
Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community. J Bone Joint Surg Am. 2021 01 06; 103(1):4-9.
-
Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. Value Health. 2021 01; 24(1):105-111.
-
Genes Contributing to the Unique Biology and Intrinsic Antibiotic Resistance of Enterococcus faecalis. mBio. 2020 11 24; 11(6).